Neurocrine Biosciences | NBIX - Ebit





Ebit Changement Date
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -48.28M 37.33M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Cytokinetics USD -181.23M 2.86M 2026-03
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Incyte USD 344.17M 39.71M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Pfizer USD 4.99B 340M 2026-03
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Repligen USD 19.98M 13K 2026-03
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Xoma USD -10.08M 4.4M 2024-06